In trading on Monday, shares of SpringWorks Therapeutics Inc (Symbol: SWTX) crossed above their 200 day moving average of $39.93, changing hands as high as $40.79 per share. SpringWorks ...
6d
Mutual of America Capital Management LLC trimmed its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free ...
J.P. Morgan said its top biotech picks for 2025 were Vertex, Travere, SpringWorks, PTC Therapeutics, Wave Life Sciences, ...
Massachusetts Financial Services Co. MA lifted its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 20.2% during the 3rd quarter, Holdings Channel reports. The firm ...
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases ...
Duquesne Family Office's 13F portfolio increased from $2.92B to $2.95B, with 29 significant holdings. Check out the new ...
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) director Julie Hambleton has sold a total of $186,047 worth of company stock, according to a recent SEC filing. The transactions were ...
As of November 12 at 9:30 a.m. EST. Market Open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback